Posterior Segment Eye Disorder Treatment Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Posterior Segment Eye Disorder Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Posterior Segment Eye Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Posterior Segment Eye Disorder Treatment Overall Market Size
2.1 Global Posterior Segment Eye Disorder Treatment Market Size: 2021 VS 2028
2.2 Global Posterior Segment Eye Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Posterior Segment Eye Disorder Treatment Players in Global Market
3.2 Top Global Posterior Segment Eye Disorder Treatment Companies Ranked by Revenue
3.3 Global Posterior Segment Eye Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Posterior Segment Eye Disorder Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Posterior Segment Eye Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Posterior Segment Eye Disorder Treatment Players in Global Market
3.6.1 List of Global Tier 1 Posterior Segment Eye Disorder Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Posterior Segment Eye Disorder Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Posterior Segment Eye Disorder Treatment Market Size Markets, 2021 & 2028
4.1.2 Glaucoma Treatment
4.1.3 Age-related Macular Degeneration (AMD) Treatment
4.1.4 Diabetic Retinopathy (DR) Treatment
4.2 By Type - Global Posterior Segment Eye Disorder Treatment Revenue & Forecasts
4.2.1 By Type - Global Posterior Segment Eye Disorder Treatment Revenue, 2017-2022
4.2.2 By Type - Global Posterior Segment Eye Disorder Treatment Revenue, 2023-2028
4.2.3 By Type - Global Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Posterior Segment Eye Disorder Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Posterior Segment Eye Disorder Treatment Revenue & Forecasts
5.2.1 By Application - Global Posterior Segment Eye Disorder Treatment Revenue, 2017-2022
5.2.2 By Application - Global Posterior Segment Eye Disorder Treatment Revenue, 2023-2028
5.2.3 By Application - Global Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Posterior Segment Eye Disorder Treatment Market Size, 2021 & 2028
6.2 By Region - Global Posterior Segment Eye Disorder Treatment Revenue & Forecasts
6.2.1 By Region - Global Posterior Segment Eye Disorder Treatment Revenue, 2017-2022
6.2.2 By Region - Global Posterior Segment Eye Disorder Treatment Revenue, 2023-2028
6.2.3 By Region - Global Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Posterior Segment Eye Disorder Treatment Revenue, 2017-2028
6.3.2 US Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.3.3 Canada Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.3.4 Mexico Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Posterior Segment Eye Disorder Treatment Revenue, 2017-2028
6.4.2 Germany Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4.3 France Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4.4 U.K. Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4.5 Italy Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4.6 Russia Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.4.8 Benelux Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Posterior Segment Eye Disorder Treatment Revenue, 2017-2028
6.5.2 China Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.5.3 Japan Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.5.4 South Korea Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.5.6 India Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Posterior Segment Eye Disorder Treatment Revenue, 2017-2028
6.6.2 Brazil Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.6.3 Argentina Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Posterior Segment Eye Disorder Treatment Revenue, 2017-2028
6.7.2 Turkey Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.7.3 Israel Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
6.7.5 UAE Posterior Segment Eye Disorder Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Posterior Segment Eye Disorder Treatment Major Product Offerings
7.1.4 Novartis Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.1.5 Novartis Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Posterior Segment Eye Disorder Treatment Major Product Offerings
7.2.4 Allergan Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.2.5 Allergan Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Posterior Segment Eye Disorder Treatment Major Product Offerings
7.3.4 Pfizer Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Akorn
7.4.1 Akorn Corporate Summary
7.4.2 Akorn Business Overview
7.4.3 Akorn Posterior Segment Eye Disorder Treatment Major Product Offerings
7.4.4 Akorn Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.4.5 Akorn Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Posterior Segment Eye Disorder Treatment Major Product Offerings
7.5.4 Teva Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.5.5 Teva Key News
7.6 Bausch & Lomb
7.6.1 Bausch & Lomb Corporate Summary
7.6.2 Bausch & Lomb Business Overview
7.6.3 Bausch & Lomb Posterior Segment Eye Disorder Treatment Major Product Offerings
7.6.4 Bausch & Lomb Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.6.5 Bausch & Lomb Key News
7.7 Otsuka Pharmaceutical
7.7.1 Otsuka Pharmaceutical Corporate Summary
7.7.2 Otsuka Pharmaceutical Business Overview
7.7.3 Otsuka Pharmaceutical Posterior Segment Eye Disorder Treatment Major Product Offerings
7.7.4 Otsuka Pharmaceutical Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.7.5 Otsuka Pharmaceutical Key News
7.8 Santen
7.8.1 Santen Corporate Summary
7.8.2 Santen Business Overview
7.8.3 Santen Posterior Segment Eye Disorder Treatment Major Product Offerings
7.8.4 Santen Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.8.5 Santen Key News
7.9 Lunan Pharma
7.9.1 Lunan Pharma Corporate Summary
7.9.2 Lunan Pharma Business Overview
7.9.3 Lunan Pharma Posterior Segment Eye Disorder Treatment Major Product Offerings
7.9.4 Lunan Pharma Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.9.5 Lunan Pharma Key News
7.10 Zizhu Pharma
7.10.1 Zizhu Pharma Corporate Summary
7.10.2 Zizhu Pharma Business Overview
7.10.3 Zizhu Pharma Posterior Segment Eye Disorder Treatment Major Product Offerings
7.10.4 Zizhu Pharma Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.10.5 Zizhu Pharma Key News
7.11 Bayer
7.11.1 Bayer Corporate Summary
7.11.2 Bayer Business Overview
7.11.3 Bayer Posterior Segment Eye Disorder Treatment Major Product Offerings
7.11.4 Bayer Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.11.5 Bayer Key News
7.12 Roche
7.12.1 Roche Corporate Summary
7.12.2 Roche Business Overview
7.12.3 Roche Posterior Segment Eye Disorder Treatment Major Product Offerings
7.12.4 Roche Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.12.5 Roche Key News
7.13 Alimera Sciences
7.13.1 Alimera Sciences Corporate Summary
7.13.2 Alimera Sciences Business Overview
7.13.3 Alimera Sciences Posterior Segment Eye Disorder Treatment Major Product Offerings
7.13.4 Alimera Sciences Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.13.5 Alimera Sciences Key News
7.14 Regeneron Pharmaceuticals
7.14.1 Regeneron Pharmaceuticals Corporate Summary
7.14.2 Regeneron Pharmaceuticals Business Overview
7.14.3 Regeneron Pharmaceuticals Posterior Segment Eye Disorder Treatment Major Product Offerings
7.14.4 Regeneron Pharmaceuticals Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.14.5 Regeneron Pharmaceuticals Key News
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Corporate Summary
7.15.2 Boehringer Ingelheim Business Overview
7.15.3 Boehringer Ingelheim Posterior Segment Eye Disorder Treatment Major Product Offerings
7.15.4 Boehringer Ingelheim Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.15.5 Boehringer Ingelheim Key News
7.16 Kowa Group
7.16.1 Kowa Group Corporate Summary
7.16.2 Kowa Group Business Overview
7.16.3 Kowa Group Posterior Segment Eye Disorder Treatment Major Product Offerings
7.16.4 Kowa Group Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.16.5 Kowa Group Key News
7.17 Ohr Pharmaceutical
7.17.1 Ohr Pharmaceutical Corporate Summary
7.17.2 Ohr Pharmaceutical Business Overview
7.17.3 Ohr Pharmaceutical Posterior Segment Eye Disorder Treatment Major Product Offerings
7.17.4 Ohr Pharmaceutical Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.17.5 Ohr Pharmaceutical Key News
7.18 Quark Pharmaceuticals
7.18.1 Quark Pharmaceuticals Corporate Summary
7.18.2 Quark Pharmaceuticals Business Overview
7.18.3 Quark Pharmaceuticals Posterior Segment Eye Disorder Treatment Major Product Offerings
7.18.4 Quark Pharmaceuticals Posterior Segment Eye Disorder Treatment Revenue in Global Market (2017-2022)
7.18.5 Quark Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Posterior Segment Eye Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. Posterior Segment Eye Disorder Treatment Market Drivers in Global Market
Table 3. Posterior Segment Eye Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of Posterior Segment Eye Disorder Treatment in Global Market
Table 5. Top Posterior Segment Eye Disorder Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Posterior Segment Eye Disorder Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Posterior Segment Eye Disorder Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Posterior Segment Eye Disorder Treatment Product Type
Table 9. List of Global Tier 1 Posterior Segment Eye Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Posterior Segment Eye Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Posterior Segment Eye Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Posterior Segment Eye Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Posterior Segment Eye Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Posterior Segment Eye Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Posterior Segment Eye Disorder Treatment Product Offerings
Table 32. Novartis Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Posterior Segment Eye Disorder Treatment Product Offerings
Table 35. Allergan Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Posterior Segment Eye Disorder Treatment Product Offerings
Table 38. Pfizer Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Akorn Corporate Summary
Table 40. Akorn Posterior Segment Eye Disorder Treatment Product Offerings
Table 41. Akorn Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Posterior Segment Eye Disorder Treatment Product Offerings
Table 44. Teva Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bausch & Lomb Corporate Summary
Table 46. Bausch & Lomb Posterior Segment Eye Disorder Treatment Product Offerings
Table 47. Bausch & Lomb Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Otsuka Pharmaceutical Corporate Summary
Table 49. Otsuka Pharmaceutical Posterior Segment Eye Disorder Treatment Product Offerings
Table 50. Otsuka Pharmaceutical Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Santen Corporate Summary
Table 52. Santen Posterior Segment Eye Disorder Treatment Product Offerings
Table 53. Santen Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Lunan Pharma Corporate Summary
Table 55. Lunan Pharma Posterior Segment Eye Disorder Treatment Product Offerings
Table 56. Lunan Pharma Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Zizhu Pharma Corporate Summary
Table 58. Zizhu Pharma Posterior Segment Eye Disorder Treatment Product Offerings
Table 59. Zizhu Pharma Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Bayer Corporate Summary
Table 61. Bayer Posterior Segment Eye Disorder Treatment Product Offerings
Table 62. Bayer Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Roche Corporate Summary
Table 64. Roche Posterior Segment Eye Disorder Treatment Product Offerings
Table 65. Roche Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Alimera Sciences Corporate Summary
Table 67. Alimera Sciences Posterior Segment Eye Disorder Treatment Product Offerings
Table 68. Alimera Sciences Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Regeneron Pharmaceuticals Corporate Summary
Table 70. Regeneron Pharmaceuticals Posterior Segment Eye Disorder Treatment Product Offerings
Table 71. Regeneron Pharmaceuticals Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Boehringer Ingelheim Corporate Summary
Table 73. Boehringer Ingelheim Posterior Segment Eye Disorder Treatment Product Offerings
Table 74. Boehringer Ingelheim Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Kowa Group Corporate Summary
Table 76. Kowa Group Posterior Segment Eye Disorder Treatment Product Offerings
Table 77. Kowa Group Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Ohr Pharmaceutical Corporate Summary
Table 79. Ohr Pharmaceutical Posterior Segment Eye Disorder Treatment Product Offerings
Table 80. Ohr Pharmaceutical Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Quark Pharmaceuticals Corporate Summary
Table 82. Quark Pharmaceuticals Posterior Segment Eye Disorder Treatment Product Offerings
Table 83. Quark Pharmaceuticals Posterior Segment Eye Disorder Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Posterior Segment Eye Disorder Treatment Segment by Type in 2021
Figure 2. Posterior Segment Eye Disorder Treatment Segment by Application in 2021
Figure 3. Global Posterior Segment Eye Disorder Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Posterior Segment Eye Disorder Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Posterior Segment Eye Disorder Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Posterior Segment Eye Disorder Treatment Revenue in 2021
Figure 8. By Type - Global Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 12. US Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 24. China Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Posterior Segment Eye Disorder Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Posterior Segment Eye Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Akorn Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch & Lomb Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Otsuka Pharmaceutical Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Santen Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lunan Pharma Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zizhu Pharma Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Roche Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Alimera Sciences Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Regeneron Pharmaceuticals Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Boehringer Ingelheim Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Kowa Group Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Ohr Pharmaceutical Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Quark Pharmaceuticals Posterior Segment Eye Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)